Concord Medical Services
6 hedge funds and large institutions have $3.02M invested in Concord Medical Services in 2018 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 2 closing their positions.
41% more capital invested
Capital invested by funds: $2.15M → $3.02M (+$876K)
0% less ownership
Funds ownership: 0.06% → 0.06% (-0%)
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
25% less funds holding
Funds holding: 8 → 6 (-2)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$3.52K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LPL Financial
San Diego,
California
|
-$29K |
| 2 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$23K |
| 3 |
Renaissance Technologies
New York
|
-$19.3K |
CCM Hedge Fund Activity: Q2 2018 in Review
6 of the 4,384 institutional investors tracked by Wall St. Rank reported a position in Concord Medical Services (CCM) for Q2 2018, worth a combined $3.02M — up 41% from $2.15M a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of CCM and 0 opened new positions — a net loss of 2 holders — while 1 trimmed existing stakes and 1 added.
The largest buyer was UBS Group, adding an estimated $3.52K. The largest seller was LPL Financial, exiting entirely with an estimated $29K sold.
- 6 institutional investors held Concord Medical Services (CCM) as of Q2 2018, down from 8 in Q1 2018.
- Funds reported $3.02M of Concord Medical Services stock for Q2 2018, up 41% quarter-over-quarter.
- 0 funds opened new Concord Medical Services positions in Q2 2018 and 2 closed out, a net change of -2 holders.
- The largest Concord Medical Services buyer in Q2 2018 was UBS Group, an estimated $3.52K added.
- The largest Concord Medical Services seller in Q2 2018 was LPL Financial, an estimated $29K sold.
Based on aggregated 13F filings for Q2 2018.